CNGB3
protein-codingcyclic nucleotide gated channel subunit beta 3, the group of Cyclic nucleotide gated channels
Gene summary
This gene encodes the beta subunit of a cyclic nucleotide-gated ion channel. The encoded beta subunit appears to play a role in modulation of channel function in cone photoreceptors. This heterotetrameric channel is necessary for sensory transduction, and mutations in this gene have been associated with achromatopsia 3, progressive cone dystrophy, and juvenile macular degeneration, also known as Stargardt Disease. [provided by RefSeq, Feb 2010]
- ACHM3
- ACHM1
- RMCH
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~189.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0000455
Submitter: Orphanet
Inheritance Pattern: Unknown
Disease ID:MONDO:0009549
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0018852
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009875
Submitter: Natera
Inheritance Pattern: AR
Disease ID:MONDO:0009875
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0009875
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0100446
Submitter: ClinGen
The CNGB3 gene was first reported in relation to autosomal recessive CNB3-related retinopathy in 2000 in an individual described as having achromatopsia (Sundin et. Al., 2000; PMID 10888875). Achromatopsia is characterized by photophobia, reduced visual acuity, nystagmus, and inability to discriminate between colors. Electroretinogram shows an absent cone response whereas rod function is preserved. This condition was curated under the disesae entity "CNGB3-related retinopathy". The maximum score for genetic evidence was achieved by the addition of 5 variants (PMID:10888875, 15657609, 31544997) in this curation, however there is more evidence available in the literature. There are over 200 CNGB3 pathogenic and likely pathogenic variants listed on ClinVar (10/05/2021). In one report (PMID 15657609), a cohort of 341 unrelated patients with achromatopsia was studied which resulted in identification of disease-causing variants in 163 patients. Among them, 105 were homozygous for the variant while 44 were compound heterozygotes, 14 carried a single allele. Another study reported a deep intronic variant NM_019098.4(CNGB3):c.1663-1205G>A in-trans with pathogenic variants in 18 patients with achromatopsia, making this variant one of the most frequent variant associated with achromatopsia (PMID 31544997). CNGB3 and CNGA3 proteins were found to be highly expressed in NRL-/- mouse retinas by western blotting and immunolabeling. Moreover, both these cone CNG channels were observed to co-localize in S and M cones (PMID 18665891). Mouse studies also supported the role of Cngb3 in cone function. A mice line with naturally occurring missense variant NM_013927:c.692G>A; p.(R231H) was studied for visual function which revealed that homozygous mice (n=12) had lost cone function while their rod function was intact (PMID 30592498). Additionally, in another knockout mouse study, homozygous null mice recapitulated achromatopsia phenotype, briefly by showing a decrease in photopic ERG responses, visual acuity, and cone density (PMID 19767295). Role of CNGB3 in cone function was also further supported by rescue studies in null mice by sub-retinal injections of AAV8(Y447,&33F) constructs. The transgenic mice showed expression of CNGB3 in cone cells and restored photopic ERG responses (PMID 32305965). In summary, CNGB3 is definitively associated with autosomal recessive CNGB3-related retinopathy. This has been repeatedly demonstrated in both research and clinical diagnostic settings, and has been upheld over time.
Clinical Genomic Database (CGD)
Manifestation: Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CNGB3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_019098.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 12 | 314 | 2 | 328 | ||
| missense | 4 | 18 | 380 | 34 | 3 | 439 |
| nonsense | 55 | 22 | 3 | 3 | 83 | |
| start loss | 3 | 3 | ||||
| frameshift | 91 | 54 | 4 | 2 | 151 | |
| splice donor/acceptor (+/-2bp) | 19 | 55 | 3 | 77 | ||
| Total | 169 | 152 | 402 | 353 | 5 | 1081 |
Highest pathogenic variant AF is 0.0022731433
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_061971.3 | 18 | MANE Select | |
| Ensembl | ENSP00000316605.5 | 18 | MANE Select | |
| Ensembl | ENSP00000428329.1 | 3 | Standard | |
| Ensembl | ENSP00000505959.1 | 15 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- cAMP signaling pathway - Homo sapiens (human)
- NO-cGMP-PKG mediated Neuroprotection
- Visual signal transduction: Cones
Biological Process
- cation transport
- signal transduction
- visual perception
- cation transmembrane transport
Molecular Function
- intracellular cAMP-activated cation channel activity
- intracellular cGMP-activated cation channel activity
- cGMP binding
Cellular Component
- photoreceptor outer segment
- transmembrane transporter complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000320005
- Coding exons
- 18
- Length
- 189699
- Individuals with no LoFs
- 125081
- Homozygous LoFs
- 2
- Heterozygous LoFs
- 665
- Defined
- 125748
- p
- 0.00266
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -1.18 | 485 | 417 | 1.16 | 0.0000221 | 5289 |
| Missense (PolyPhen) | 107 | 99.568 | 1.0746 | 1321 | ||
| Synonymous | -0.619 | 160 | 150 | 1.06 | 0.00000846 | 1527 |
| Loss of Function | 1.46 | 34 | 44.5 | 0.765 | 0.00000246 | 555 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00087 | 0.00086 | rare |
| Latino/Admixed American | 0.0043 | 0.0043 | notable |
| Ashkenazi Jewish | 0.0014 | 0.0014 | notable |
| East Asian | 0.00071 | 0.00071 | rare |
| Finnish | 0.0028 | 0.0028 | notable |
| European (Non-Finnish) | 0.0033 | 0.0033 | notable |
| South Asian | 0.00092 | 0.00091 | rare |
| Other | 0.0029 | 0.0029 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Visual signal transduction is mediated by a G-protein coupled cascade using cGMP as second messenger. This protein can be activated by cGMP which leads to an opening of the cation channel and thereby causing a depolarization of rod photoreceptors. Induced a flickering channel gating, weakened the outward rectification in the presence of extracellular calcium, increased sensitivity for L-cis diltiazem and enhanced the cAMP efficiency of the channel when coexpressed with CNGA3 (By similarity). Essential for the generation of light-evoked electrical responses in the red-, green- and blue sensitive cones. {ECO:0000250, ECO:0000269|PubMed:10888875}.;
- Disease
- DISEASE: Achromatopsia 3 (ACHM3) [MIM:262300]: An autosomal recessive, ocular stationary disorder due to the absence of functioning cone photoreceptors in the retina. It is characterized by total colorblindness, low visual acuity, photophobia and nystagmus. Achromatopsia type 3 patients manifest severe myopia. {ECO:0000269|PubMed:10888875, ECO:0000269|PubMed:10958649, ECO:0000269|PubMed:12357335, ECO:0000269|PubMed:14757870, ECO:0000269|PubMed:15657609, ECO:0000269|PubMed:15712225}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Intolerance Scores
- LoFtool
- 0.221
- RVIS EVS
- 1.67
- RVIS percentile EVS
- 96.33
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.256
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |